Drug Topics
NOVEMBER 7, 2023
A Q&A with Ginny Langbehn, vice president of marketing and communications at American Associated Pharmacies, about different strategies pharmacies can use to bring in new customers.
Pharmacy Times
NOVEMBER 7, 2023
AI may help to significantly speed up drug discovery and development, and help researchers end the treatment-resistant infection crisis before it’s too late.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
NOVEMBER 7, 2023
The FDA is advising health care professionals who administer the vaccine to make sure the correct volume of the vaccine is withdrawn from the vial and the correct dose is administered to the patient.
STAT
NOVEMBER 7, 2023
More than two dozen attorneys general are urging Food and Drug Administration officials to take urgent action to address disparities in how well pulse oximeters, the fingertip devices used to monitor a person’s oxygen levels, work on people with darker skin. In a Nov. 1 letter, the AGs noted that it had been a year since the FDA convened a public meeting of experts , who called for clearer labeling and more rigorous testing of the devices, and that no action had been taken.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
NOVEMBER 7, 2023
Understanding critical risk factors associated with the use of electronic nicotine delivery systems (ENDS) may help mitigate the harm dealt to youths by such devices.
STAT
NOVEMBER 7, 2023
Longtime cancer doctor Monica Bertagnolli is finally heading to the National Institutes of Health director’s office after a nearly two-year effort to install a permanent leader atop the $48 billion science agency. The Senate voted 62-36 Tuesday to confirm her nomination, giving the White House clearance to officially name Bertagnolli the institute’s director, the second woman ever to fill the role.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
NOVEMBER 7, 2023
Infants younger than 6 months old are the highest risk for severe RSV infection, so researchers aim to target this group for prevention methods
The Guardian - Pharmaceutical Industry
NOVEMBER 7, 2023
Cure any ailment! Never known to fail! Early medicine adverts made grand claims but they look alarming today The confusion with patent medicines starts with the name, since they were rarely ever patented; manufacturers just thought it sounded cool. Bamboozling was always part of the package: from the 17th century, concoctions of water, alcohol and herbs were sold with wild claims and exotic origin stories.
STAT
NOVEMBER 7, 2023
Over the past few years, researchers have started using AI to capture signals from our voices in hopes of quickly diagnosing diseases. Academics and startup founders in the nascent field talked about the potential benefits, as well as the privacy implications, of this technology at the Milken Institute Future of Health Summit on Tuesday. “There’s a very rich set of data for us to look at,” said Nate Blaylock, chief technology officer at voice AI company Canary Speech.
Pharmacy Times
NOVEMBER 7, 2023
More studies are needed to show conclusive benefits on patient functionality.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
NOVEMBER 7, 2023
You’re reading the web edition of D.C. Diagnosis. Sign up here to receive this newsletter in your inbox on Tuesdays and Thursdays. On the hot seat, feeling the Bern Drug executives will soon have the chance to tell Congress why they’re suing Medicare over price negotiations when their companies sell drugs to all the other governments that negotiate prices, my colleague John Wilkerson reports.
Pharmacy Times
NOVEMBER 7, 2023
With appointment-based models in community pharmacy, researchers have noted that community pharmacies are well suited for identifying and addressing social determinants of health.
STAT
NOVEMBER 7, 2023
WASHINGTON — The pandemic showed how fragile the supply chain can be, and to fix it, the United States needs to treat health care like a national security issue, said experts at a health conference here on Monday. Rep. Debbie Dingell (D-Mich.), speaking on a panel at the Milken Institute’s Future of Health Summit, warned that if the country had another pandemic or faced a bacterial biowarfare threat, “and we don’t have the capability to produce antibiotics in our coun
Pharmacy Times
NOVEMBER 7, 2023
Investigators found that there was no association of dementia incidence in insulin use at 5 years after stopping metformin and an association at 0.07 years for HbA1C level at year 1.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
NOVEMBER 7, 2023
During the pandemic, in search of tools to keep patients healthy and virus-free, doctors turned to a new technology for help: remote patient monitoring. In 2020, home use of tools like connected blood pressure cuffs, continuous glucose monitors, and weight scales shot up, with billing for the devices and their associated care more than quadrupling. As use of remote patient monitoring has continued to grow — albeit at a slower rate than during the early-pandemic surge — data on its
Fierce Healthcare
NOVEMBER 7, 2023
Hims & Hers' strong revenue growth streak continued in the third quarter as the digital health and wellness business brought in $227 million, up 57% from a year ago. | With continued strong revenue growth, Hims & Hers expects to be profitable by the first half of 2024. The digital health and wellness company boosted its revenue outlook for the year and announced a new AI-powered service to personalize treatments.
STAT
NOVEMBER 7, 2023
After years of trying, the Food and Drug Administration is again seeking to withdraw approval of an antibiotic that is widely used by farmers to control diarrhea in their pigs, but has generated controversy over links to cancer. At issue is carbadox , which, since the 1970s, has been added to livestock feed to combat diarrhea in young pigs after they are weaned from their mothers, as well as to promote growth.
PharmaVoice
NOVEMBER 7, 2023
23andMe always had bigger aims than at-home genetics testing. In this in-depth interview, the company’s founder explains its foray into pharma, drug R&D, solving cold cases and more.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
NOVEMBER 7, 2023
Kindbody, a fast-growing fertility chain, knowingly exposed countless eggs and embryos to unsafe conditions and suffered repeated embryo mix-ups, according to a months-long Bloomberg investigation published recently. Here we go again.
Pharmacy Times
NOVEMBER 7, 2023
Pricing is also a key issue, as many insurance plans do not cover these medications’ use for obesity.
STAT
NOVEMBER 7, 2023
Making good on a recent threat, the Federal Trade Commission is challenging more than 100 patents on brand-name medicines that were improperly or inaccurately listed by some of the world’s biggest drug companies in a key government registry. The agency notified 10 companies that listings for dozens of patents on such medicines as asthma inhalers and epinephrine autoinjectors are being disputed.
Pharmacy Times
NOVEMBER 7, 2023
With precision medicine, patients undergoing treatment are living longer without disease recurrence or progression and with fewer adverse effects, resulting in preservation of quality of life.
STAT
NOVEMBER 7, 2023
WASHINGTON (AP) — As U.S. doctors scale back their use of opioid painkillers , a new option for hard-to-treat pain is taking root: ketamine, the decades-old surgical drug that is now a trendy psychedelic therapy. Prescriptions for ketamine have soared in recent years, driven by for-profit clinics and telehealth services offering the medication as a treatment for pain, depression, anxiety and other conditions.
pharmaphorum
NOVEMBER 7, 2023
Frontiers Health 23 - Day 1 from the marvellous Auditorium della Tecnica in Rome, where we are set to bring you the biggest news stories, trends, and industry insights
European Pharmaceutical Review
NOVEMBER 7, 2023
Positive results for a combination treatment using the first Fc-silent investigational monoclonal antibody in pivotal clinical trials that is designed to block and bind to the T-cell immunoreceptor with Ig and ITIM domains (TIGIT), have been announced. The treatment is being evaluated in patients with upper GI adenocarcinomas. Domvanalimab plus the antibody zimberelimab and chemotherapy showed encouraging overall response rate and six-month progression-free survival (PFS) rate results in a preli
pharmaphorum
NOVEMBER 7, 2023
In this week’s episode of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Raquel Izumi, chief operating officer and co-founder of Vincerx Pharma, who is on a mission to improve antibody drug conjugate (or ADC) drug development, aiming to conquer cancer with safe, well-tolerated, and paradigm-shifting therapeutics.
Fierce Pharma
NOVEMBER 7, 2023
Pfizer’s $3.5 billion cost-savings drive has made its way overseas. | The layoffs at Pfizer's Newbridge, Kildare, manufacturing site are the latest in the company's effort to save $3.5 billion by 2024 amid declining demand for its COVID-19 products.
pharmaphorum
NOVEMBER 7, 2023
BioNTech flashes the cash, adding tumour drug in $1bn deal Phil.
STAT
NOVEMBER 7, 2023
In August 2013, the FDA made news when it issued cybersecurity guidance for medical devices. But several years earlier, government officials recognized the risk: Soon after the FDA made its announcement, former Vice President Dick Cheney revealed in a “60 Minutes” interview that when his pacemaker was replaced in 2007, his doctors took precautions to make it hack-proof.
Outsourcing Pharma
NOVEMBER 7, 2023
A breast cancer drug that has been used for many years to treat the disease, has been licensed today (November 7) as a preventative measure.
pharmaphorum
NOVEMBER 7, 2023
Søren Møller, managing partner for seed investments at Novo Holdings, has successfully supported numerous healthcare startups through strategic investments.
STAT
NOVEMBER 7, 2023
Top of the morning to you. Gray skies are hovering over the Pharmalot campus right now, but our spirits remain sunny, nonetheless. Why? We will trot out a bit of insight from the Morning Mayor, who would say, “Every new day should be unwrapped like a precious gift.” To celebrate the notion, we are brewing still more cups of stimulation and invite you to join us.
pharmaphorum
NOVEMBER 7, 2023
CARGO eyes $300m IPO against lacklustre listings backdrop Phil.
Expert insights. Personalized for you.
530 
Let's personalize your content